LTRN Earnings Lantern Pharma Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.30 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -1.57 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -1.21 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.82 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.42 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -1.93 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -1.39 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.97 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.51 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -1.47 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -1.08 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.79 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.36 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -1.31 | 2024-03-18 | 10-K |
| Q3 2023 | 2022-09-30 | -1.00 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.79 | 2023-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.